期刊文献+

心肌细胞生长激素信号传导与MAPK超家族 被引量:1

GROWTH HORMONE SIGNAL TRANSDUCTION AND MAPK SUPERFAMILY IN CARDIAC MYOCYTES
暂未订购
导出
摘要 生长激素刺激培养新生大鼠心肌细胞,用含MBP凝胶分离法测定细胞外信号调节酶(ERK)活性。用WesternBlooting法检测磷酸化的p38MAPK,观察心肌细胞内MAPK超家族活性变化,探讨心肌细胞GH信号传导途径。结果发现:生长激素激活心肌细胞ERKs呈时间和浓度依赖性关系。而对p38MAPK无磷酸化激活作用。表明心肌生长激素信号传导通过MAPK超家族成员ERK途径,而与p38MAPK途径无关。生长激素诱导的心肌细胞ERK激活,可能是生长激素心脏效应的重要机制之一。 The cultured cardiac myocytes of neonatal rats were stimulated by growth hormone (GH),and then the activity of extracellular signal-regulated kinase(ERK) was assayed with the method of MBP-containing gel and the phosphorylated p38MAPK was detected with Western Blotting.The changes of MAPK superfamily activities were observed to explore GH signal transduction pathway in cardiac myocytes.The results showed that GH activated ERKs in cardiac myocytes in a time- and a dose-dependent manners, however,GH did not cause phospho-activation of p38MAPK in cardiac myocytes.This study indicates that GH signal transduction in cardiac myocytes is closely related to ERK,a member of MAPK superfamily,but is not relevant to p38MAPK pathway.GH-induced ERK activation in cardiac myocytes may be one of the important mechanisms by which GH affects the heart.
出处 《南通医学院学报》 1998年第3期296-298,共3页 ACTA Academiae Medicinae Nantong
基金 国家教委留学回国人员基金 日本文部省心血管研究基金
关键词 生长激素 P38MAPK 心肌细胞 信号传导 Growth hormone Extracellular signal-regulated kinase(ERK) p38MAPK Cardiac myocytes
  • 相关文献

同被引文献9

  • 1Colao A, Marzullo P, Di Somma C, et al. Growth hormone and the heart. Clin Endocrinol,(Oxf) 2001, 54:137-154.
  • 2Lombardi G, Colao A, Marzullo P,et al. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol, 1997, 155 Suppl1: S33-37.
  • 3Anker SD, Volterrani M, Pflaum CD, et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol, 2001, 38:443-452.
  • 4Volterrani M,Desenzani P, Lorusso R, et al. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet, 1997,349:1067.
  • 5Osterziel KJ, Strohm O, Schuler J, et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet, 1998, 351:1233-1237.
  • 6Isgaard J, Bergh CH, Caidahl K, et al. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J, 1998, 19:1704-1711.
  • 7Adamopoulos S, Parissis JT, Georgiadis M, et al. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. Am Heart J, 2002, 144:359-364.
  • 8Cohn JN, Bristow MR, Chien KR, et al. Report of the national heart, lung, and blood institute special emphasis panel on heart failure research. Circulation, 1997, 95:766-770.
  • 9李静,庞其捷,李铜铃.人生长激素和胰岛素样生长因子-Ⅰ:作用的分子机制[J].国外医学(内分泌学分册),1999,19(3):113-116. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部